Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

How can clinical trial units and networks help deliver high quality cancer trials

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019

Published: 7 Jan 2020

Views: 703

Rating:

Save

Prof Usha Menon - University College London, London, UK

Prof Usha Menon presents a talk on 'How can clinical trial units and networks help deliver high quality cancer trials' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Time toxicity: the burden on cancer patients

Dr Arjun Gupta - University of Minnesota, Minneapolis, USA

Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )

The time toxicity of cancer care

Dr Arjun Gupta - University of Minnesota, Minneapolis, USA

The time toxicity of cancer care ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

VT3989 is safe and well tolerated in patients with advanced malignant...

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA

Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )

More from ecancer